Future Directions in DLBCL: Innovations in the Frontline and Relapsed Settings

(MedPage Today) — Ahead of the upcoming American Society of Hematology (ASH) annual meeting, Alex Niu, MD, of Roswell Park Comprehensive Cancer Center in Buffalo, New York, discusses the evolving therapeutic landscape for diffuse large B-cell…

Source link : https://www.medpagetoday.com/meetingcoverage/ashfuturefocusdlbcl/118786

Author :

Publish date : 2025-12-02 17:17:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Future Directions in DLBCL: Innovations in the Frontline and Relapsed Settings

Join the Lifeline Chorus and Help Fight AMR

Polypharmacy Is a Real Issue. Dismantling Public Health Won’t Fix It.

Related Posts

GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity

FDA Approves At-Home Device for Treatment-Resistant Depression

FDA Calls for New Warning on Flu Shots

Exercise vs Meds for Depression; Supplement’s Suicide Risk; Grants Terminated

U.S. Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

What’s in a Name? A New One Might Help PCOS Patients

GLP-1 Drugs Tied to Mortality Reduction in Colon Cancer Patients With Obesity

FDA Approves At-Home Device for Treatment-Resistant Depression

FDA Calls for New Warning on Flu Shots

Exercise vs Meds for Depression; Supplement’s Suicide Risk; Grants Terminated

U.S. Overdose Deaths Fell Through Most of 2025, Federal Data Reveal

What’s in a Name? A New One Might Help PCOS Patients

Cardiovascular Risk Score Shows Value in Predicting Future Eye Disease

FDA Requests Removal of Suicide Warning on GLP-1s

Categories

Archives